The impact of obstructive sleep apnea syndrome (OSAS) on the arterial baroreflex, and its significance, is still under debate. We investigated the baroreflex sensitivity (BRS) during sleep in well-selected OSAS patient and control subject cohorts Methods: We performed a prospective study of 10 non-OSAS subjects, 14 subjects with mild-tomoderate OSAS, and 14 male subjects with severe OSAS subjects. Groups were matched for age, body mass index, and other relevant variables. Subjects had no other disease and were not receiving regular medication. BP was monitored beat-by-beat (Portapres; Finapres Medical Systems; Amsterdam, the Netherlands) at night during polysomnography. Spontaneous BRS was assessed by the sequence technique. Heart-rate correction was also applied to calculate BRS at a heart rate (HR) of 60 beats/min (BRS-60) to account for intersubject variability in baseline HR. Eight suitable patients were treated with continuous positive airway pressure (CPAP), and BRS measurements were repeated 6 weeks later. Results: BRS and BRS-60 were significantly lower in patients with severe OSAS than in patients with mild-to-moderate OSAS and in non-OSAS subjects, and a separate sleep-stage analysis revealed this difference to be evident in stage 2 non-rapid eye movement sleep and during nocturnal wakefulness. There was no difference in BRS and BRS-60 between non-OSAS subjects and patients with mild-to-moderate OSAS. In multivariate analysis, the desaturation index was the only independent predictor of depressed BRS. CPAP therapy significantly improved the BRS measures.
O
bstructive sleep apnea syndrome (OSAS) is a highly prevalent disorder 1 and is associated with cardiovascular diseases. 2, 3 Therapy with continuous positive airway pressure (CPAP) decreases cardiovascular morbidity and mortality. 4, 5 The repetitive periods of hypoxia during sleep in patients with OSAS acting through peripheral chemoreflexes facilitate surges of BP and sympathetic nerve activity. [6] [7] [8] [9] Moreover, there is evidence of augmented sympathetic activity during wakefulness in OSAS patients, which may contribute to the cardiovascular pathophysiology. 6, 10 A proposed mechanism for the enhanced sympathetic drive in OSAS patients during the daytime is decreased baroreflex sensitivity (BRS). Baroreceptors, located in the walls of the carotid arteries and the aorta, sense systemic BP by the extent of their stretch, and the normal arterial baroreflex buffers short-term changes in BP by feedback modulation in heart rate (HR), cardiac contractility, and vascular resistance. 11 Low BRS is common in patients with hypertension, 12, 13 diabetes, 14 congestive cardiac failure, 15 or coronary artery disease, 16 and is associated Original Research SLEEP MEDICINE with a poor prognosis following myocardial infarction. 17 Various studies have reported BRS in OSAS patients during the daytime, with some indicating depressed BRS 18, 19 and some reporting unaltered BRS. 20, 21 While the difference in BRS between OSAS patients and control subjects during wakefulness might be small, there is a much lower increase in BRS from wakefulness to sleep in OSAS patients than in control populations. 7, 22 Only one study 23 has addressed the question of BRS in OSAS during sleep, and it was found to be depressed in untreated patients. However, one potential limitation of this study was the inclusion of inadequately matched control subjects for body mass index (BMI) since BRS is significantly affected by obesity 24 -26 and is correctable by weight loss. 27 A further potential confounding factor in previous reports has been the influence of basal HR on BRS. One study 28 detected a highly significant relationship between BRS and prevailing HR within individuals and determined that BRS measures at lower HR can be affected by changes in HR of only a few beats per minute. Thus, the authors proposed that HR corrections be used in the correct assessment of BRS.
The effects of CPAP therapy on autonomic dysfunction and BRS are still under debate. Short-term CPAP therapy in OSAS patients results in reduced sympathetic nerve activity 6 and BRS 29 during sleep, although catecholamine levels remain high. 30 Longer treatment also shows a decrease in sympathetic nerve traffic during wakefulness 31, 32 and an improvement in BRS during sleep. 23 We performed a prospective controlled study in tightly selected groups of OSAS patients and control subjects to evaluate the relationship of OSAS with spontaneous BRS during sleep and to determine the independent predictors of decreased BRS in OSAS patients.
Materials and Methods

Subjects
Consecutive male subjects with suspected OSAS and no other medical disorder who were not receiving medication were considered for the study, which was approved by the hospital ethics committee. Also recruited from the general population were age-matched and BMI-matched healthy male snorers. All subjects gave written, informed consent. BP was measured in the supine position three times during daytime. Polysomnography was performed as previously described. 33 The desaturation index (DI) was determined by the frequency of desaturations of Ն 4% per hour. Arterial BP was measured beat-by-beat (Portapres; Finapres Medical Systems; Amsterdam, the Netherlands). Two cuffs were positioned on the middle phalanx of the third and fourth fingers with the device alternating fingers every 30 min, and the hand to which the measurement unit was applied was held in constant position. Eight suitable subjects with severe OSAS initiated CPAP therapy within 1 week. BRS measurements were repeated after 6 weeks.
Data Processing To Obtain BRS
The ECG and BP signals were digitally sampled, and spontaneous BRS was measured using the direct-sequence technique. 34 Sequences of three or more consecutive beats in which systolic BP (SBP) and pulse intervals (PIs) concurrently increased (ϩPI/ ϩSBP) or decreased (-PI/-SBP) were identified. Values of ϩPI/ϩSBP and -PI/-SBP were averaged for the estimation of BRSϩ, a measure of baroreceptor activation, or BRS-, a measure of baroreceptor deactivation, respectively. The data were analyzed for the overnight measurements and for separate sleep stages.
A factor in calculating BRS is that for a given subject the value of BRS relates to the HR at which it was measured. 28, 35 For example, a ϩ 1-mm Hg change in SBP may cause an increase of 10 ms in PI when the subject's HR is 60 beats/min; the same 1-mm Hg increase may cause a change of only 5 ms in PI when the subject's baseline HR is 120 beats/min. Thus, to compare BRS values across subjects, one should take into account the baseline HR at which sensitivities are calculated. To account for the natural intersubject variation in HR, we calculated the HR-corrected BRS at an HR of 60 beats/min (BRS-60), as described. 28, 35 This measure is calculated as follows. The PI range for each subject was divided into five equal sections with the natural logarithm of the combined activation and deactivation BRS sequence estimates and their corresponding PI averaged. The calculated mean HRs were plotted against the corresponding averaged logarithmic BRS. A straight line was fitted to the data using linear regression analysis. The equation of this regression was used to normalize the BRS-60 estimates.
Statistical Analysis
Baseline characteristics are expressed as the mean Ϯ SD or the median (interquartile range [IQR]), depending on their distribution and compared by one-way analysis of variance followed by post hoc analysis or Wilcoxon rank sum test for independent samples, and the paired t test was used for paired samples. Categoric variables were compared using the 2 test. Univariate correlation among BRS, baseline, and polysomnography variables was assessed by Pearson correlation analysis. To assess the relative strength of the association, we used a linear stepwise regression model with BRS variables as the dependent variables, and age, BMI, smoking status, Epworth sleepiness scale (ESS) score, and various polysomnography parameters as independent variables. Statistical analysis was performed using a commercial software package (SPSS, version 11; SPSS; Chicago, IL).
Results
Subjects
Baseline data of the study population are in Table  1 . Subjects were classified according to their apneahypopnea index (AHI) as non-OSAS (AHI Յ 5), mild/moderate OSAS (AHI Ͼ 5, Յ 30), or severe OSAS (AHI Ͼ 30). The three groups were similar in demographics (ie, age and BMI), smoking status, BP, and lipid profile. None had clinical evidence of another medical disorder, and their biochemical profiles, including liver and renal function, cardiac enzyme levels, and resting ECG, were normal. AHI, oximetry data, and ESS score were different among 
Nocturnal BP, HR, and BRS
Nocturnal HR and BP measurements are in Table  2 . HR was higher in patients with severe OSAS than in patients in other groups over the total period and particularly in stage 2 non-rapid eye movement (NREM) sleep and nocturnal wakefulness, but there was no difference between the HRs of the groups of non-OSAS subjects and the patients with mild-tomoderate OSAS. Nocturnal SBP and diastolic BP (DBP) were similar across the three groups, but there was a significant difference in DBP between patients with severe OSAS and mild-to-moderate OSAS overall and in stage 2 NREM sleep.
The number of positive and negative ramps was similar in all three groups in all sleep stages. Spontaneous BRSϩ, BRS-, and BRS-60 measurements were significantly different among the three groups (p Ͻ 0.05 [analysis of variance]) and were lower in the severe OSAS group than in the non-OSAS and the mild-to-moderate OSAS groups (Fig 1) . There was no significant difference between the non-OSAS and the mild-to-moderate OSAS groups. A separate analysis of different sleep stages revealed this difference in stage 2 NREM sleep and during nocturnal wakefulness, but not in REM and slow-wave sleep ( Table 3) .
The results of the univariate correlation analysis are in Table 4 , and they demonstrate a significant relationship between BRS and BMI, ESS score, and all polysomnography parameters. However, stepwise linear regression analysis identified the DI as the only independent predictor for all BRS measures ( Table 5) .
Effect of CPAP Therapy
After 6 weeks of CPAP therapy, there was no change in BMI. CPAP therapy significantly im- proved all BRS measures (Fig 2) . However, there was no change in mean nocturnal HR (70 Ϯ 11 vs 68 Ϯ 7, respectively; p ϭ 0.521) or SBP (129 Ϯ 17 vs 121 Ϯ 18, respectively; p ϭ 0.068) and DBP (68 Ϯ 10 vs 66 Ϯ 8, respectively; p ϭ 0.334). The improvement in BRS did not correlate with objective compliance.
Discussion
These data indicate depressed spontaneous BRS in patients with severe OSAS, especially in stage 2 NREM sleep and during nocturnal wakefulness, and a significant improvement after 6 weeks of effective CPAP therapy. The present study has a number of strengths compared to some previous reports. First, we took great care in patient selection to exclude any with a cardiovascular or other medical disorder. Thus, the population allows the evaluation of potential relationships between BRS and OSAS without the potential influence of other confounding factors. Second, the patient and control groups were similar in important demographic and clinical variables. Third, our study allows for the first time a separate assessment for patients with mild-to-moderate disease. Fourth, by the use of HR correction techniques we have shown that the observed changes in BRS are not simply an artificial reflection of altered HR between subjects.
Bonsignore et al 23 studied patients with severe OSAS during sleep, and the authors came to similar conclusions as the present report. However, these authors did not allow for the possible confounding effects of obesity, and several studies have suggested that there is an inverse correlation between BMI and BRS. 24 -27,36,37 However, BMI was not a predictor for BRS in our study, unlike markers of OSAS severity. Previous studies assessing the relationship between obesity and BRS did not allow for the possible impact of OSAS. Thus, it seems likely that the presence of OSAS supersedes the independent effect of obesity, which is also supported by a small study 38 on obese OSAS patients who demonstrated lower BRS than did obese healthy subjects. However, to address the independent effects of OSAS and obesity and BRS, a separate study should be performed including nonobese and obese patient and control populations.
For the first time in the analysis of data from OSAS patients, we employed HR correction for the BRS measures. This has been previously suggested on the basis of a highly significant relationship between BRS and prevailing HR within individuals, so that subjects with a higher HR demonstrate artificially lower BRS than subjects with a lower HR. 28 A normalization of BRS at 60 beats/min 28 as well as at 100 beats/min 35 has been suggested. We chose to use the correction to 60 beats/min as an HR of 100 beats/min rarely occurs during sleep in healthy individuals. The HR correction values shown in this study support an independent relationship between OSAS and depressed BRS. While our data indicate depressed BRS in patients with severe OSAS, there was no significant difference between non-OSAS subjects and patients with mild-to-moderate OSAS, suggesting an unaltered autonomic function in these patients. This may also explain the significantly better cardiovascular outcome of these patients than in patients with severe OSAS. 5 However, mild-to-moderate disease will progress to severe disease 39 in many patients, who therefore will need to be followed up carefully. Furthermore, some evidence suggests depressed BRS during sleep in snoring subjects. 40 However, our group of non-OSAS subjects consisted exclusively of snorers, so this point is unlikely to have influenced our analysis.
Multivariate analysis identified the DI, which is the principal marker of severity of intermittent hypoxia in OSAS patients, as the strongest predictor for depressed BRS. In contrast, the AHI and other oximetry markers such as the percentage of total sleep time spent at Ͻ 90% Sao 2 or the mean Sao 2 did not correlate with BRS measurements. In general, acute hypoxia stimulates peripheral chemoreceptors, which evoke an increase in sympathetic outflow with the consequence of an increase in BP 41 ; this response to hypoxia is potentiated in OSAS patients. 8 As a possible explanation of these findings, Peng and Prabhakar 42 identified in a rat model that chronic intermittent hypoxia results in selective augmentation of the carotid body sensitivity to hypoxia and concluded that this mechanism at least in part contributes to enhanced sympathetic activity and increased BP. Moreover, a recent study 43 found an inhibition of the BRS in rats exposed to intermittent hypoxia. Beside the responses of the chemoreceptors and baroreceptors, intermittent hypoxia has other pathophysiologic consequences that differ from responses to chronic sustained hypoxia. We have previously demonstrated 33 a selective activation of inflammatory pathways over adaptive pathways, resulting in the production of proinflammatory, atherogenic cytokines and chemokines in OSAS patients. 44 These data in addition to the present findings indicate that the repetitive episodes of reoxygenation might be particularly important in the acute cardiovascular changes occurring in OSAS patients, and, thus, it underlines the central role of intermittent hypoxia in the development of cardiovascular consequences. Effective CPAP therapy prevents apneas and associated oxygen desaturations, and improves cardiovascular outcome. 4, 5 In our study, treatment with CPAP for 6 weeks increased the BRS, which is consistent with previous findings. 23, 31, 32 The BRS increase did not correlate with compliance; however, the number of treated patients in our study is relatively small to allow detailed analysis and conclusion. Nevertheless, the significant improvement in BRS is all the more striking given the relatively small number and, thus, points toward a great benefit of this treatment modality in reducing sympathetic activation and subsequent cardiovascular complications.
Studies assessing BRS have shown different feasibilities with different methods, and there is no "gold standard" as yet. Traditionally, BRS was assessed by the injection of vasoactive substances. Over recent years, noninvasive techniques to measure BRS have emerged. Here, we used the direct sequence method to measure BRS, which relates spontaneous fluctuations in BP to corresponding fluctuations in HR. This method has been validated in various situations including sleep. [45] [46] [47] It offers a major advantage for sleep studies, since it requires no active intervention on the patients with the effect of arousals and subsequent increases in BP and HR. 48 Moreover, a 2005 study 49 comparing different methods in various maneuvers suggested a preference for the sequence technique. A potential limitation of this method is the possible influence of respiration on HR, and we cannot exclude a potential bias of this effect on our data. However, previous studies 7, 23, 50 in OSAS patients have suggested that this influence is relatively small and not of major significance, and, furthermore, preliminary analysis of our data using alternative methods such as the coherence and the ␣-index techniques (data not shown) yielded results that were superimposable on those obtained with the sequence technique, suggesting a true correlation of BRS with OSAS. In conclusion, the present data provide evidence for a specific role of intermittent hypoxia in depressed baroreceptor function in OSAS patients and suggest that this dysfunction is improvable by effective CPAP therapy.
